FdaApplication
NDA 212819
Identifiers
- fda_app_no: NDA212819
Properties
| Property | Value |
|---|---|
| applicant_name | MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC |
| application_type | NDA |
| approval_date | 2019-07-16 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RECARBRIO | CILASTATIN SODIUM; IMIPENEM; RELEBACTAM | EQ 500MG BASE/VIAL;500MG/VIAL;250MG/VIAL | POWDER;INTRAVENOUS |
1 product